Association between the oral microbiome and brain resting state connectivity in schizophrenia

Dongdong Lin, Zening Fu, Jingyu Liu, Nora I. Perrone‐Bizzozero, Kent E. Hutchison, Juan Bustillo, Yuhui Du, Godfrey D. Pearlson, Vince D. Calhoun

TL;DR

This study investigates the link between the oral microbiome and brain functional connectivity in individuals with schizophrenia (SZ). By analyzing saliva microbiome and resting-state fMRI data, researchers found significant differences in oral microbial composition and brain connectivity between SZ patients and healthy controls, suggesting a potential role for the oral microbiome in SZ pathophysiology.

What Problem Does This Paper Address?

Schizophrenia (SZ) is a complex neuropsychiatric disorder with a significant genetic component, but environmental factors are also known to play a crucial role. While the gut microbiome-brain axis has been extensively studied, the influence of the oral microbiome on brain function and its potential involvement in SZ remains less understood. This paper aims to bridge this knowledge gap by exploring the association between oral microbial dysbiosis and altered brain functional connectivity in SZ. Understanding this connection could shed light on novel diagnostic biomarkers and therapeutic targets for SZ.

Methods

The study employed a multi-modal approach combining high-throughput microbial 16S rRNA sequencing and resting-state functional magnetic resonance imaging (rsfMRI).

  • Oral Microbiome Analysis: Saliva samples were collected and subjected to 16S rRNA sequencing. Preprocessing involved demultiplexing, quality control (DADA2), and taxonomic assignment using the Greengenes database. Microbial composition was analyzed using weighted UniFrac and Bray-Curtis distances, with permutational MANCOVA used to assess group differences. Differential abundance testing was performed using DESeq2. A sparse partial least square discriminant analysis (sPLS-DA) was used to identify key microbial species contributing to the distinction between SZ and healthy controls (HC). Functional pathways were predicted using PICRUSt and analyzed for group differences.
  • Brain Functional Connectivity Analysis: rsfMRI data were preprocessed using the Group Independent Component Analysis (GICA) method to derive independent functional networks and calculate functional network connectivity (FNC) matrices. A spatially constrained ICA algorithm with a standardized template was used. Group differences in FNC were assessed using multiple linear regression.
  • Integrative Analysis: A multivariate method, DIABLO (Data Integration Analysis for Biomarker discovery using a Latent cOmponents), was employed to integrate microbiome and FNC data, identifying associations and evaluating classification performance for SZ.

Datasets

  • Participants: 213 individuals were included in the study: 110 with schizophrenia (SZ) and 103 healthy controls (HC). Of these, 139 participants had both microbiome and rsfMRI data.
  • Microbiome Data: Oral microbiome composition was assessed from saliva samples using 16S rRNA sequencing.
  • fMRI Data: Resting-state fMRI data were collected from a subset of participants.

Key Insights and Ideas

  • Oral Microbiome Shift in SZ: Significant differences in oral microbiome composition were observed between SZ patients and HCs, even after controlling for age and sex. This suggests that oral dysbiosis is a feature associated with schizophrenia.
  • Specific Microbial Signatures: Several bacterial species, particularly those involved in hydrogen sulfide (H2S) production (e.g., Atopobium, Veillonella, Lautropia), were found to be significantly altered in SZ. H2S is implicated in various physiological processes and has been linked to SZ pathophysiology.
  • Altered Brain Connectivity: The study identified significant differences in brain functional connectivity (FNC) between SZ and HC groups. Reduced connectivity was observed in networks related to sensory-motor and visual domains, while increased connectivity was noted in cross-domain networks.
  • Microbiome-Brain Link: A significant correlation (r=0.46) was found between oral microbiome composition and brain functional connectivity. This suggests a potential pathway through which oral microbial changes might influence brain function in SZ.
  • Classification Potential: The integrated analysis of microbiome and FNC data demonstrated a strong ability to classify SZ patients from HCs, with AUC values of 0.835 for the microbiome component and 0.871 for the FNC component. This highlights the potential of these biomarkers for diagnostic purposes.
  • Functional Pathway Dysregulation: Predicted metabolic pathways in the oral microbiome showed significant differences between SZ and HC groups. Depleted pathways were involved in biosynthesis, while enriched pathways were related to glucose fermentation and peptidoglycan biosynthesis, suggesting altered metabolic functions in the oral microbiome of SZ patients.

Key Results

  • Significant differences in oral microbiome composition between SZ and HC groups were detected using weighted UniFrac (p=1.3×10⁻³) and Bray-Curtis (p=0.013) distances.
  • A multivariate analysis (sPLS-DA) showed that the first component derived from microbiome OTUs could classify SZ from HC with an AUC of 0.78.
  • 123 FNCs showed significant differences between SZ and HC groups (FDR<0.05).
  • A correlation of r=0.46 was achieved between the first pair of components from oral microbiome and FNC data.
  • The integrated analysis using DIABLO achieved classification AUCs of 0.835 for the microbiome component and 0.871 for the FNC component in distinguishing SZ from HC.
  • 16 MetaCyc pathways showed significant abundance differences between SZ and HC groups after FDR correction.

Limitations and Future Work

The authors acknowledge several limitations:

  • Causality: The study demonstrates associations, but the causal relationship between oral microbiome shifts and brain functional network alterations in SZ is not determined.
  • Sample Size and Heterogeneity: The relatively small sample size and potential heterogeneity in SZ patients (e.g., treatment, care) could influence the findings.
  • Confounding Factors: While efforts were made to control for covariates, other factors like medications, dentition history, smoking, alcohol use, and metabolic syndrome could confound the results.

Future work suggested includes:

  • Replication studies with larger populations to strengthen the findings.
  • Stricter criteria for participant selection and inclusion of more clinical metrics in analyses.
  • Further investigation into the role of gut microbiome in conjunction with oral microbiome to provide a more comprehensive understanding of microbiome-brain interactions in SZ.
  • Exploring the potential of these findings for developing novel biomarkers and therapeutic targets for neurological syndromes.

Summary updated

Abstract

Recent microbiome-brain axis findings have shown evidence of the modulation of microbiome community as an environmental mediator in brain function and psychiatric illness. This work is focused on the role of the microbiome in understanding a rarely investigated environmental involvement in schizophrenia (SZ), especially in relation to brain circuit dysfunction. We leveraged high throughput microbial 16s rRNA sequencing and functional neuroimaging techniques to enable the delineation of microbiome-brain network links in SZ. N=213 SZ and healthy control (HC) subjects were assessed for the oral microbiome. Among them, 139 subjects were scanned by resting-state functional magnetic resonance imaging (rsfMRI) to derive brain functional connectivity. We found a significant microbiome compositional shift in SZ beta diversity (weighted UniFrac distance, p= 6×10 <sup>-3</sup> ; Bray-Curtis distance p = 0.021). Fourteen microbial species involving pro-inflammatory and neurotransmitter signaling and H <sub>2</sub> S production, showed significant abundance alterations in SZ. Multivariate analysis revealed one pair of microbial and functional connectivity components showing a significant correlation of 0.46. Thirty five percent of microbial species and 87.8% of brain functional network connectivity from each component also showed significant differences between SZ and HC with strong performance in classifying SZ from HC, with an area under curve (AUC) = 0.84 and 0.87, respectively. The results suggest a potential link between oral microbiome dysbiosis and brain functional connectivity alteration in relation to SZ, possibly through immunological and neurotransmitter signaling pathways and the hypothalamic-pituitary-adrenal axis, supporting for future work in characterizing the role of oral microbiome in mediating effects on SZ brain functional activity.
BibTeX
@inproceedings{lin2024association,
  author = {Dongdong Lin and Zening Fu and Jingyu Liu and Nora I. Perrone‐Bizzozero and Kent E. Hutchison and Juan Bustillo and Yuhui Du and Godfrey D. Pearlson and Vince D. Calhoun},
  title = {{Association between the oral microbiome and brain resting state connectivity in schizophrenia}},
  booktitle = {Schizophrenia},
  year = {2024},
  doi = {10.1016/j.schres.2024.06.045},
}
Figure